Lipocine Inc. (LPCN)

Lipocine Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3.35	6.21	4.77	3.15	2.95	19.22
Short-Term Investments	16.36	15.43	17.26	29.38	41.67	0.45
Cash & Short-Term Investments	19.72	21.63	22.04	32.53	44.62	19.67
Cash Growth	-19.95%	-1.82%	-32.26%	-27.09%	126.86%	39.80%
Accounts Receivable	-	-	-	0.58	-	-
Other Receivables	0.18	0.12	0.05	0.08	0.25	0
Receivables	0.18	0.12	0.05	0.66	0.25	0
Prepaid Expenses	0.43	0.57	0.77	0.95	1.51	0.66
Restricted Cash	-	-	-	-	-	5
Total Current Assets	20.33	22.32	22.86	34.14	46.38	25.33
Property, Plant & Equipment	0.15	0.17	0.12	0.13	0.01	-
Long-Term Investments	-	-	-	-	2.02	-
Long-Term Accounts Receivable	-	-	-	3.25	4.05	-
Other Long-Term Assets	0.02	0.02	0.02	0.02	0.02	0.02
Total Assets	20.5	22.51	23	37.54	52.48	25.35
Accounts Payable	0.36	0.27	1.4	0.6	1.29	1.6
Accrued Expenses	0.27	0.48	1.22	1.08	1.02	1.65
Current Portion of Long-Term Debt	-	-	-	-	2.31	3.33
Current Portion of Leases	0.35	0.44	-	-	-	-
Current Unearned Revenue	0.32	0.32	-	-	-	-
Other Current Liabilities	-	-	0.02	-	1	-
Total Current Liabilities	1.3	1.51	2.63	1.68	5.62	6.58
Long-Term Debt	-	-	-	-	-	2.26
Other Long-Term Liabilities	-	-	-	0.23	1.3	1.17
Total Liabilities	1.3	1.51	2.63	1.91	6.91	10.01
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	220.86	220.79	220.17	219.11	218.29	187.41
Retained Earnings	-201.63	-199.77	-199.78	-183.43	-172.67	-172.03
Treasury Stock	-0.04	-0.04	-0.04	-0.04	-0.04	-0.04
Comprehensive Income & Other	0.01	0.01	0.01	-0.02	-0.02	-
Shareholders' Equity	19.2	21	20.37	35.63	45.57	15.34
Total Liabilities & Equity	20.5	22.51	23	37.54	52.48	25.35
Total Debt	0.35	0.44	-	-	2.31	5.59
Net Cash (Debt)	19.37	21.19	22.04	32.53	44.33	14.08
Net Cash Growth	-20.26%	-3.82%	-32.26%	-26.62%	214.90%	103.40%
Net Cash Per Share	3.62	3.91	4.18	6.19	8.60	4.30
Filing Date Shares Outstanding	5.35	5.35	5.32	5.21	5.19	5.19
Total Common Shares Outstanding	5.35	5.35	5.32	5.21	5.19	4.12
Working Capital	19.03	20.81	20.23	32.46	40.76	18.75
Book Value Per Share	3.59	3.93	3.83	6.84	8.77	3.72
Tangible Book Value	19.2	21	20.37	35.63	45.57	15.34
Tangible Book Value Per Share	3.59	3.93	3.83	6.84	8.77	3.72
Machinery	-	1.39	1.3	1.29	1.15	1.14

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q